“It is just a setup for everything challenging about the pandemic that we’ve had until now, which is confusion, inequity, delays, reliance on testing,” CP3 Director Dr. Walid Gellad told the New York Times about antibody treatments for COVID-19.
“It is just a setup for everything challenging about the pandemic that we’ve had until now, which is confusion, inequity, delays, reliance on testing,” CP3 Director Dr. Walid Gellad told the New York Times about antibody treatments for COVID-19.